-
公开(公告)号:US20100331293A1
公开(公告)日:2010-12-30
申请号:US12823767
申请日:2010-06-25
申请人: Timothy D. Cushing , Paul John Dransfield , Felix Gonzalez Lopez De Turiso , Michael G. Johnson , Todd Kohn , Vatee Pattaropong , Jillian L. Simard
发明人: Timothy D. Cushing , Paul John Dransfield , Felix Gonzalez Lopez De Turiso , Michael G. Johnson , Todd Kohn , Vatee Pattaropong , Jillian L. Simard
IPC分类号: A61K31/5377 , A61K31/541 , A61K31/506 , A61K31/4709 , C07D417/14 , C07D413/14 , C07D401/14 , A61P35/00 , A61P19/02 , A61P29/00 , A61P37/00
CPC分类号: C07D401/04 , C07D215/44 , C07D401/12 , C07D401/14 , C07D407/14 , C07D409/12 , C07D413/14 , C07D417/14 , C07D471/04
摘要: Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjogren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.
摘要翻译: 取代的双环杂芳基和含有它们的组合物,用于治疗一般炎症,关节炎,风湿性疾病,骨关节炎,炎性肠病,炎症性眼病,炎症性或不稳定性膀胱病,牛皮癣,皮肤炎症成分的投诉,慢性炎性病症 不限于自身免疫性疾病如系统性红斑狼疮(SLE),重症肌无力,类风湿性关节炎,急性播散性脑脊髓炎,特发性血小板减少性紫癜,多发性硬化症,干燥综合征和自身免疫性溶血性贫血,包括所有形式的超敏反应的过敏症状 包括但不限于白血病,例如急性骨髓性白血病(AML)骨髓增生异常综合征(MDS)骨髓增生性疾病(MPD)慢性骨髓性白血病(MPD)慢性骨髓性白血病(MPD)的介导,依赖或与p110δ活性相关的癌症的方法 CML)T细胞急性淋巴细胞白血病(T-ALL)B细胞急性淋巴细胞白血病(B-ALL)非霍奇金淋巴瘤(NHL)B细胞淋巴瘤和实体瘤如乳腺癌。
-
公开(公告)号:US08940724B2
公开(公告)日:2015-01-27
申请号:US12823767
申请日:2010-06-25
申请人: Timothy D. Cushing , Paul John Dransfield , Felix Gonzalez Lopez de Turiso , Michael G. Johnson , Todd Kohn , Vatee Pattaropong , Jillian L. Simard
发明人: Timothy D. Cushing , Paul John Dransfield , Felix Gonzalez Lopez de Turiso , Michael G. Johnson , Todd Kohn , Vatee Pattaropong , Jillian L. Simard
IPC分类号: C07D401/04 , C07D215/44 , C07D401/12 , C07D401/14 , C07D407/14 , C07D409/12 , C07D413/14 , C07D417/14 , C07D471/14 , C07D471/04
CPC分类号: C07D401/04 , C07D215/44 , C07D401/12 , C07D401/14 , C07D407/14 , C07D409/12 , C07D413/14 , C07D417/14 , C07D471/04
摘要: Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjogren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.
摘要翻译: 取代的双环杂芳基和含有它们的组合物,用于治疗一般炎症,关节炎,风湿性疾病,骨关节炎,炎性肠病,炎症性眼病,炎症性或不稳定性膀胱病,牛皮癣,皮肤炎症成分的投诉,慢性炎性病症 不限于自身免疫性疾病如系统性红斑狼疮(SLE),重症肌无力,类风湿性关节炎,急性播散性脑脊髓炎,特发性血小板减少性紫癜,多发性硬化症,干燥综合征和自身免疫性溶血性贫血,包括所有形式的超敏反应的过敏症状 包括但不限于白血病,例如急性骨髓性白血病(AML)骨髓增生异常综合征(MDS)骨髓增生性疾病(MPD)慢性骨髓性白血病(MPD)慢性骨髓性白血病(MPD)的介导,依赖或与p110δ活性相关的癌症的方法 CML)T细胞急性淋巴细胞白血病(T-ALL)B细胞急性淋巴细胞白血病(B-ALL)非霍奇金淋巴瘤(NHL)B细胞淋巴瘤和实体瘤如乳腺癌。
-
公开(公告)号:US20130090323A1
公开(公告)日:2013-04-11
申请号:US13701936
申请日:2011-06-30
申请人: Paul John Dransfield , Felix Gonzalez Lopez De Turiso , Todd Kohn , Vatee Pattaropong , Jillian L. Simard
发明人: Paul John Dransfield , Felix Gonzalez Lopez De Turiso , Todd Kohn , Vatee Pattaropong , Jillian L. Simard
IPC分类号: C07D471/04 , C07D413/14
CPC分类号: C07D471/04 , A61K31/4375 , A61K31/4709 , C07D401/12 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D491/107
摘要: Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110 activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.
-
公开(公告)号:US20130079342A1
公开(公告)日:2013-03-28
申请号:US13701912
申请日:2011-06-30
IPC分类号: C07D413/14
CPC分类号: C07D413/14 , C07D401/14 , C07D473/16
摘要: Substituted bicyclic heteroaryls of the following formulae and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110 activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.
摘要翻译: 下列配方的取代的双环杂芳基和含有它们的组合物,用于治疗一般炎症,关节炎,风湿性疾病,骨关节炎,炎性肠病,炎症性眼病,炎性或不稳定性膀胱病,牛皮癣,皮肤炎症成分的投诉,慢性炎症 包括但不限于自身免疫疾病如系统性红斑狼疮(SLE),重症肌无力,类风湿性关节炎,急性播散性脑脊髓炎,特发性血小板减少性紫癜,多发性硬化症,Sjoegren综合征和自身免疫性溶血性贫血,包括所有形式的超敏反应的过敏性疾病, 本发明还使得能够治疗依赖于p110活性或与p110活性相关的癌症的方法,包括但不限于白血病,例如急性骨髓性白血病(AML)Myelo-dysplastic综合征(MDS)骨髓增殖性疾病(MPD) C 慢性骨髓性白血病(CML)T细胞急性淋巴细胞白血病(T-ALL)B细胞急性淋巴细胞白血病ALL)非霍奇金淋巴瘤(NHL)B细胞淋巴瘤和实体瘤,如乳腺癌。
-
公开(公告)号:US08030354B2
公开(公告)日:2011-10-04
申请号:US12287036
申请日:2008-10-03
申请人: Sean P. Brown , Qiong Cao , Paul John Dransfield , Xiaohui Du , Zice Fu , Jonathan Houze , Xian Yun Jiao , Yong-Jae Kim , Todd J. Kohn , SuJen Lai , An-Rong Li , Daniel Lin , Jiwen Liu , Jian Luo , Julio C. Medina , Jeffrey D. Reagan , Vatee Pattaropong , Margrit Schwarz , Wang Shen , Yongli Su , Gayathri Swaminath , Marc Vimolratana , Yingcai Wang , Yumei Xiong , Li Yang , Ming Yu , Jie Zhang , Liusheng Zhu
发明人: Sean P. Brown , Qiong Cao , Paul John Dransfield , Xiaohui Du , Zice Fu , Jonathan Houze , Xian Yun Jiao , Yong-Jae Kim , Todd J. Kohn , SuJen Lai , An-Rong Li , Daniel Lin , Jiwen Liu , Jian Luo , Julio C. Medina , Jeffrey D. Reagan , Vatee Pattaropong , Margrit Schwarz , Wang Shen , Yongli Su , Gayathri Swaminath , Marc Vimolratana , Yingcai Wang , Yumei Xiong , Li Yang , Ming Yu , Jie Zhang , Liusheng Zhu
IPC分类号: A61K31/192 , C07C53/134
CPC分类号: C07C323/62 , C07C59/68 , C07C59/72 , C07C217/54 , C07C217/62 , C07C317/22 , C07C323/19 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/10 , C07C2601/14 , C07C2601/16 , C07C2601/18 , C07C2602/42 , C07C2603/74 , C07D213/64 , C07D309/12
摘要: The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: where the definitions of the variables are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.
摘要翻译: 本发明提供了可用于例如治疗受试者的代谢紊乱的化合物。 这些化合物具有通式I:其中本文提供变量的定义。 本发明还提供了组合物,其包括化合物在制备药物和用于治疗代谢性疾病例如II型糖尿病中的使用方法。
-
公开(公告)号:US20090137561A1
公开(公告)日:2009-05-28
申请号:US12287036
申请日:2008-10-03
申请人: Sean P. Brown , Qiong Cao , Paul John Dransfield , Xiaohui Du , Jonathan Houze , Xian Yun Jiao , Yong-Jae Kim , Todd J. Kohn , SuJen Lai , An-Rong Li , Daniel Lin , Jian Luo , Julio C. Medina , Jeffrey D. Reagan , Vatee Pattaropong , Margrit Schwarz , Wang Shen , Yongli Su , Gayathri Swaminath , Marc Vimolratana , Xiang Wang , Yumei Xiong , Li Yang , Ming Yu , Jie Zhang , Liusheng Zhu
发明人: Sean P. Brown , Qiong Cao , Paul John Dransfield , Xiaohui Du , Jonathan Houze , Xian Yun Jiao , Yong-Jae Kim , Todd J. Kohn , SuJen Lai , An-Rong Li , Daniel Lin , Jian Luo , Julio C. Medina , Jeffrey D. Reagan , Vatee Pattaropong , Margrit Schwarz , Wang Shen , Yongli Su , Gayathri Swaminath , Marc Vimolratana , Xiang Wang , Yumei Xiong , Li Yang , Ming Yu , Jie Zhang , Liusheng Zhu
IPC分类号: C07C59/48 , A61K31/192 , A61K31/235 , C07C69/76 , C07D309/00 , A61K31/351 , C07D211/20 , A61K31/445 , A61K31/44 , A61K31/55 , C07D223/04 , A61P7/00
CPC分类号: C07C323/62 , C07C59/68 , C07C59/72 , C07C217/54 , C07C217/62 , C07C317/22 , C07C323/19 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/10 , C07C2601/14 , C07C2601/16 , C07C2601/18 , C07C2602/42 , C07C2603/74 , C07D213/64 , C07D309/12
摘要: The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: where the definitions of the variables are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.
-
公开(公告)号:US08686137B2
公开(公告)日:2014-04-01
申请号:US13701772
申请日:2011-06-30
申请人: Paul John Dransfield
发明人: Paul John Dransfield
IPC分类号: C07D417/14 , A61K31/5377
CPC分类号: C07D417/14
摘要: Compounds having the structure which are selective inhibitors of P13K (phosphatidylinositol 3-kinase-delta), for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions.
摘要翻译: 具有P13K(磷脂酰肌醇3-激酶-δ)选择性抑制剂,用于治疗一般炎症,关节炎,风湿性疾病,骨关节炎炎性肠病,炎症性眼病,炎性或不稳定性膀胱疾病,牛皮癣,皮肤症状的结构的化合物 与炎症成分,慢性炎症状况。
-
公开(公告)号:US20130143882A1
公开(公告)日:2013-06-06
申请号:US13701772
申请日:2011-06-30
申请人: Paul John Dransfield
发明人: Paul John Dransfield
IPC分类号: A61K31/5377 , C07D417/14
CPC分类号: C07D417/14
摘要: Compounds having the structure which are selective inhibitors of P13K (phosphatidylinositol 3-kinase-delta), for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions.
摘要翻译: 具有P13K(磷脂酰肌醇3-激酶-δ)选择性抑制剂,用于治疗一般炎症,关节炎,风湿性疾病,骨关节炎炎性肠病,炎症性眼病,炎性或不稳定性膀胱疾病,牛皮癣,皮肤症状的结构的化合物 与炎症成分,慢性炎症状况。
-
-
-
-
-
-
-